nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—myenteric nerve plexus—systemic scleroderma	0.012	0.158	CbGeAlD
Paliperidone—HTR2A—pulmonary artery—systemic scleroderma	0.00852	0.112	CbGeAlD
Paliperidone—HTR1B—artery—systemic scleroderma	0.00657	0.0865	CbGeAlD
Paliperidone—HTR1D—artery—systemic scleroderma	0.00636	0.0837	CbGeAlD
Paliperidone—HTR1B—blood vessel—systemic scleroderma	0.00511	0.0674	CbGeAlD
Paliperidone—HTR1D—blood vessel—systemic scleroderma	0.00495	0.0652	CbGeAlD
Paliperidone—HTR2A—artery—systemic scleroderma	0.00316	0.0416	CbGeAlD
Paliperidone—HTR2A—endothelium—systemic scleroderma	0.00267	0.0351	CbGeAlD
Paliperidone—HTR1D—connective tissue—systemic scleroderma	0.00254	0.0334	CbGeAlD
Paliperidone—HTR2A—blood vessel—systemic scleroderma	0.00246	0.0324	CbGeAlD
Paliperidone—HRH1—connective tissue—systemic scleroderma	0.00151	0.0199	CbGeAlD
Paliperidone—ADRA2A—connective tissue—systemic scleroderma	0.00148	0.0195	CbGeAlD
Paliperidone—HRH1—smooth muscle tissue—systemic scleroderma	0.00138	0.0182	CbGeAlD
Paliperidone—ADRA2C—tendon—systemic scleroderma	0.00128	0.0168	CbGeAlD
Paliperidone—HTR2A—connective tissue—systemic scleroderma	0.00126	0.0166	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—systemic scleroderma	0.00115	0.0152	CbGeAlD
Paliperidone—DRD2—lung—systemic scleroderma	0.00115	0.0152	CbGeAlD
Paliperidone—CYP3A5—digestive system—systemic scleroderma	0.00112	0.0148	CbGeAlD
Paliperidone—ADRA2C—lung—systemic scleroderma	0.00112	0.0148	CbGeAlD
Paliperidone—HRH1—digestive system—systemic scleroderma	0.00109	0.0144	CbGeAlD
Paliperidone—HRH1—tendon—systemic scleroderma	0.00104	0.0137	CbGeAlD
Paliperidone—ADRA2A—tendon—systemic scleroderma	0.00102	0.0134	CbGeAlD
Paliperidone—CYP3A5—lung—systemic scleroderma	0.000938	0.0124	CbGeAlD
Paliperidone—HTR2A—digestive system—systemic scleroderma	0.000911	0.012	CbGeAlD
Paliperidone—HRH1—lung—systemic scleroderma	0.000911	0.012	CbGeAlD
Paliperidone—ADRA2A—lung—systemic scleroderma	0.000895	0.0118	CbGeAlD
Paliperidone—HTR2A—tendon—systemic scleroderma	0.000867	0.0114	CbGeAlD
Paliperidone—CYP3A4—digestive system—systemic scleroderma	0.000843	0.0111	CbGeAlD
Paliperidone—CYP2D6—digestive system—systemic scleroderma	0.00083	0.0109	CbGeAlD
Paliperidone—HTR2A—lung—systemic scleroderma	0.000761	0.01	CbGeAlD
Paliperidone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000604	CcSEcCtD
Paliperidone—Weight decreased—Prednisone—systemic scleroderma	0.000556	0.000602	CcSEcCtD
Paliperidone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000555	0.000601	CcSEcCtD
Paliperidone—Hyperglycaemia—Prednisone—systemic scleroderma	0.000554	0.0006	CcSEcCtD
Paliperidone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000551	0.000597	CcSEcCtD
Paliperidone—Hypotension—Lisinopril—systemic scleroderma	0.00055	0.000595	CcSEcCtD
Paliperidone—Dizziness—Captopril—systemic scleroderma	0.000549	0.000595	CcSEcCtD
Paliperidone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000547	0.000592	CcSEcCtD
Paliperidone—Depression—Prednisone—systemic scleroderma	0.000546	0.000591	CcSEcCtD
Paliperidone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00059	CcSEcCtD
Paliperidone—Urticaria—Leflunomide—systemic scleroderma	0.000544	0.000589	CcSEcCtD
Paliperidone—Body temperature increased—Leflunomide—systemic scleroderma	0.000541	0.000586	CcSEcCtD
Paliperidone—Abdominal pain—Leflunomide—systemic scleroderma	0.000541	0.000586	CcSEcCtD
Paliperidone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000538	0.000583	CcSEcCtD
Paliperidone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000582	CcSEcCtD
Paliperidone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000582	CcSEcCtD
Paliperidone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000582	CcSEcCtD
Paliperidone—Breast disorder—Methotrexate—systemic scleroderma	0.000537	0.000581	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000536	0.00058	CcSEcCtD
Paliperidone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00058	CcSEcCtD
Paliperidone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000534	0.000578	CcSEcCtD
Paliperidone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000534	0.000578	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000534	0.000578	CcSEcCtD
Paliperidone—Insomnia—Lisinopril—systemic scleroderma	0.000532	0.000576	CcSEcCtD
Paliperidone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000575	CcSEcCtD
Paliperidone—Paraesthesia—Lisinopril—systemic scleroderma	0.000528	0.000572	CcSEcCtD
Paliperidone—Vomiting—Captopril—systemic scleroderma	0.000528	0.000572	CcSEcCtD
Paliperidone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000569	CcSEcCtD
Paliperidone—Dyspnoea—Lisinopril—systemic scleroderma	0.000525	0.000568	CcSEcCtD
Paliperidone—Rash—Captopril—systemic scleroderma	0.000524	0.000567	CcSEcCtD
Paliperidone—Dermatitis—Captopril—systemic scleroderma	0.000523	0.000566	CcSEcCtD
Paliperidone—Somnolence—Lisinopril—systemic scleroderma	0.000523	0.000566	CcSEcCtD
Paliperidone—Headache—Captopril—systemic scleroderma	0.00052	0.000563	CcSEcCtD
Paliperidone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00052	0.000563	CcSEcCtD
Paliperidone—Dyspepsia—Lisinopril—systemic scleroderma	0.000518	0.00056	CcSEcCtD
Paliperidone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000516	0.000559	CcSEcCtD
Paliperidone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000516	0.000559	CcSEcCtD
Paliperidone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000558	CcSEcCtD
Paliperidone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000558	CcSEcCtD
Paliperidone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000554	CcSEcCtD
Paliperidone—Decreased appetite—Lisinopril—systemic scleroderma	0.000511	0.000554	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000508	0.00055	CcSEcCtD
Paliperidone—Fatigue—Lisinopril—systemic scleroderma	0.000507	0.000549	CcSEcCtD
Paliperidone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000549	CcSEcCtD
Paliperidone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000547	CcSEcCtD
Paliperidone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000505	0.000546	CcSEcCtD
Paliperidone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000505	0.000546	CcSEcCtD
Paliperidone—Pancreatitis—Methotrexate—systemic scleroderma	0.000504	0.000545	CcSEcCtD
Paliperidone—Constipation—Lisinopril—systemic scleroderma	0.000503	0.000545	CcSEcCtD
Paliperidone—Pain—Lisinopril—systemic scleroderma	0.000503	0.000545	CcSEcCtD
Paliperidone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000503	0.000544	CcSEcCtD
Paliperidone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000501	0.000542	CcSEcCtD
Paliperidone—Bradycardia—Prednisone—systemic scleroderma	0.000501	0.000542	CcSEcCtD
Paliperidone—Diarrhoea—Azathioprine—systemic scleroderma	0.000496	0.000537	CcSEcCtD
Paliperidone—Nausea—Captopril—systemic scleroderma	0.000494	0.000534	CcSEcCtD
Paliperidone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000492	0.000533	CcSEcCtD
Paliperidone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000491	0.000532	CcSEcCtD
Paliperidone—Asthenia—Leflunomide—systemic scleroderma	0.000491	0.000532	CcSEcCtD
Paliperidone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000485	0.000525	CcSEcCtD
Paliperidone—Pruritus—Leflunomide—systemic scleroderma	0.000484	0.000524	CcSEcCtD
Paliperidone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000483	0.000523	CcSEcCtD
Paliperidone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000521	CcSEcCtD
Paliperidone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000481	0.000521	CcSEcCtD
Paliperidone—Dysuria—Methotrexate—systemic scleroderma	0.00048	0.00052	CcSEcCtD
Paliperidone—Neutropenia—Methotrexate—systemic scleroderma	0.00048	0.00052	CcSEcCtD
Paliperidone—Dizziness—Azathioprine—systemic scleroderma	0.000479	0.000519	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000477	0.000517	CcSEcCtD
Paliperidone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000473	0.000512	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000508	CcSEcCtD
Paliperidone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000469	0.000507	CcSEcCtD
Paliperidone—Diarrhoea—Leflunomide—systemic scleroderma	0.000469	0.000507	CcSEcCtD
Paliperidone—Urticaria—Lisinopril—systemic scleroderma	0.000467	0.000506	CcSEcCtD
Paliperidone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000466	0.000505	CcSEcCtD
Paliperidone—Abdominal pain—Lisinopril—systemic scleroderma	0.000465	0.000503	CcSEcCtD
Paliperidone—Body temperature increased—Lisinopril—systemic scleroderma	0.000465	0.000503	CcSEcCtD
Paliperidone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000501	CcSEcCtD
Paliperidone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000462	0.0005	CcSEcCtD
Paliperidone—Vomiting—Azathioprine—systemic scleroderma	0.000461	0.000499	CcSEcCtD
Paliperidone—Pneumonia—Methotrexate—systemic scleroderma	0.000461	0.000498	CcSEcCtD
Paliperidone—Eye disorder—Prednisone—systemic scleroderma	0.00046	0.000497	CcSEcCtD
Paliperidone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000497	CcSEcCtD
Paliperidone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000458	0.000496	CcSEcCtD
Paliperidone—Infestation NOS—Methotrexate—systemic scleroderma	0.000458	0.000496	CcSEcCtD
Paliperidone—Infestation—Methotrexate—systemic scleroderma	0.000458	0.000496	CcSEcCtD
Paliperidone—Rash—Azathioprine—systemic scleroderma	0.000457	0.000495	CcSEcCtD
Paliperidone—Dermatitis—Azathioprine—systemic scleroderma	0.000457	0.000494	CcSEcCtD
Paliperidone—Depression—Methotrexate—systemic scleroderma	0.000457	0.000494	CcSEcCtD
Paliperidone—Flushing—Prednisone—systemic scleroderma	0.000456	0.000494	CcSEcCtD
Paliperidone—Headache—Azathioprine—systemic scleroderma	0.000454	0.000492	CcSEcCtD
Paliperidone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000491	CcSEcCtD
Paliperidone—Dizziness—Leflunomide—systemic scleroderma	0.000453	0.00049	CcSEcCtD
Paliperidone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000485	CcSEcCtD
Paliperidone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000447	0.000484	CcSEcCtD
Paliperidone—Angiopathy—Prednisone—systemic scleroderma	0.000446	0.000483	CcSEcCtD
Paliperidone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000445	0.000482	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000482	CcSEcCtD
Paliperidone—Immune system disorder—Prednisone—systemic scleroderma	0.000444	0.000481	CcSEcCtD
Paliperidone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000477	CcSEcCtD
Paliperidone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000477	CcSEcCtD
Paliperidone—Vomiting—Leflunomide—systemic scleroderma	0.000435	0.000471	CcSEcCtD
Paliperidone—Alopecia—Prednisone—systemic scleroderma	0.000435	0.00047	CcSEcCtD
Paliperidone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000434	0.000469	CcSEcCtD
Paliperidone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000433	0.000469	CcSEcCtD
Paliperidone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000432	0.000467	CcSEcCtD
Paliperidone—Epistaxis—Methotrexate—systemic scleroderma	0.000432	0.000467	CcSEcCtD
Paliperidone—Rash—Leflunomide—systemic scleroderma	0.000432	0.000467	CcSEcCtD
Paliperidone—Dermatitis—Leflunomide—systemic scleroderma	0.000431	0.000467	CcSEcCtD
Paliperidone—Mental disorder—Prednisone—systemic scleroderma	0.000431	0.000466	CcSEcCtD
Paliperidone—Nausea—Azathioprine—systemic scleroderma	0.000431	0.000466	CcSEcCtD
Paliperidone—Headache—Leflunomide—systemic scleroderma	0.000429	0.000464	CcSEcCtD
Paliperidone—Malnutrition—Prednisone—systemic scleroderma	0.000428	0.000463	CcSEcCtD
Paliperidone—Erythema—Prednisone—systemic scleroderma	0.000428	0.000463	CcSEcCtD
Paliperidone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000427	0.000462	CcSEcCtD
Paliperidone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00046	CcSEcCtD
Paliperidone—Asthenia—Lisinopril—systemic scleroderma	0.000422	0.000457	CcSEcCtD
Paliperidone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000456	CcSEcCtD
Paliperidone—Pruritus—Lisinopril—systemic scleroderma	0.000416	0.00045	CcSEcCtD
Paliperidone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000415	0.000449	CcSEcCtD
Paliperidone—Rash—Mycophenolic acid—systemic scleroderma	0.000412	0.000446	CcSEcCtD
Paliperidone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000412	0.000445	CcSEcCtD
Paliperidone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000443	CcSEcCtD
Paliperidone—Headache—Mycophenolic acid—systemic scleroderma	0.000409	0.000443	CcSEcCtD
Paliperidone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000441	CcSEcCtD
Paliperidone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000441	CcSEcCtD
Paliperidone—Nausea—Leflunomide—systemic scleroderma	0.000407	0.00044	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000406	0.000439	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—systemic scleroderma	0.000404	0.000437	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—systemic scleroderma	0.000403	0.000436	CcSEcCtD
Paliperidone—Diarrhoea—Lisinopril—systemic scleroderma	0.000403	0.000436	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000397	0.00043	CcSEcCtD
Paliperidone—Anaemia—Prednisone—systemic scleroderma	0.000396	0.000428	CcSEcCtD
Paliperidone—Agitation—Prednisone—systemic scleroderma	0.000393	0.000426	CcSEcCtD
Paliperidone—Angioedema—Prednisone—systemic scleroderma	0.000391	0.000423	CcSEcCtD
Paliperidone—Dizziness—Lisinopril—systemic scleroderma	0.000389	0.000421	CcSEcCtD
Paliperidone—Nausea—Mycophenolic acid—systemic scleroderma	0.000388	0.00042	CcSEcCtD
Paliperidone—Malaise—Prednisone—systemic scleroderma	0.000386	0.000418	CcSEcCtD
Paliperidone—Vertigo—Prednisone—systemic scleroderma	0.000385	0.000416	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—systemic scleroderma	0.000384	0.000416	CcSEcCtD
Paliperidone—Syncope—Prednisone—systemic scleroderma	0.000384	0.000416	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—systemic scleroderma	0.000383	0.000415	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000382	0.000413	CcSEcCtD
Paliperidone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000411	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—systemic scleroderma	0.000376	0.000407	CcSEcCtD
Paliperidone—Vomiting—Lisinopril—systemic scleroderma	0.000374	0.000405	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—systemic scleroderma	0.000373	0.000404	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—systemic scleroderma	0.000371	0.000402	CcSEcCtD
Paliperidone—Rash—Lisinopril—systemic scleroderma	0.000371	0.000401	CcSEcCtD
Paliperidone—Convulsion—Prednisone—systemic scleroderma	0.000371	0.000401	CcSEcCtD
Paliperidone—Dermatitis—Lisinopril—systemic scleroderma	0.000371	0.000401	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00037	0.000401	CcSEcCtD
Paliperidone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00037	0.0004	CcSEcCtD
Paliperidone—Hypertension—Prednisone—systemic scleroderma	0.00037	0.0004	CcSEcCtD
Paliperidone—Chills—Methotrexate—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Paliperidone—Headache—Lisinopril—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Paliperidone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000395	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—systemic scleroderma	0.000365	0.000394	CcSEcCtD
Paliperidone—Myalgia—Prednisone—systemic scleroderma	0.000365	0.000394	CcSEcCtD
Paliperidone—Anxiety—Prednisone—systemic scleroderma	0.000363	0.000393	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—systemic scleroderma	0.000363	0.000393	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000362	0.000392	CcSEcCtD
Paliperidone—Discomfort—Prednisone—systemic scleroderma	0.00036	0.00039	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—systemic scleroderma	0.00036	0.00039	CcSEcCtD
Paliperidone—Erythema—Methotrexate—systemic scleroderma	0.000358	0.000387	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—systemic scleroderma	0.000358	0.000387	CcSEcCtD
Paliperidone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000382	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—systemic scleroderma	0.00035	0.000379	CcSEcCtD
Paliperidone—Nausea—Lisinopril—systemic scleroderma	0.000349	0.000378	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000349	0.000378	CcSEcCtD
Paliperidone—Oedema—Prednisone—systemic scleroderma	0.000349	0.000378	CcSEcCtD
Paliperidone—Infection—Prednisone—systemic scleroderma	0.000347	0.000376	CcSEcCtD
Paliperidone—Back pain—Methotrexate—systemic scleroderma	0.000346	0.000375	CcSEcCtD
Paliperidone—Shock—Prednisone—systemic scleroderma	0.000344	0.000372	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—systemic scleroderma	0.000343	0.000371	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—systemic scleroderma	0.000341	0.000369	CcSEcCtD
Paliperidone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000369	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—systemic scleroderma	0.000339	0.000367	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—systemic scleroderma	0.000337	0.000365	CcSEcCtD
Paliperidone—Anorexia—Prednisone—systemic scleroderma	0.000333	0.00036	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000332	0.000359	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—systemic scleroderma	0.000331	0.000358	CcSEcCtD
Paliperidone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000355	CcSEcCtD
Paliperidone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000352	CcSEcCtD
Paliperidone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000351	CcSEcCtD
Paliperidone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000349	CcSEcCtD
Paliperidone—Malaise—Methotrexate—systemic scleroderma	0.000323	0.000349	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—systemic scleroderma	0.000321	0.000348	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—systemic scleroderma	0.00032	0.000347	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000318	0.000345	CcSEcCtD
Paliperidone—Insomnia—Prednisone—systemic scleroderma	0.000316	0.000342	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—systemic scleroderma	0.000314	0.00034	CcSEcCtD
Paliperidone—Cough—Methotrexate—systemic scleroderma	0.000312	0.000338	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—systemic scleroderma	0.00031	0.000336	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—systemic scleroderma	0.000308	0.000333	CcSEcCtD
Paliperidone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000331	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—systemic scleroderma	0.000305	0.00033	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—systemic scleroderma	0.000305	0.00033	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—systemic scleroderma	0.000305	0.00033	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—systemic scleroderma	0.000304	0.000329	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000303	0.000327	CcSEcCtD
Paliperidone—Fatigue—Prednisone—systemic scleroderma	0.000301	0.000326	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—systemic scleroderma	0.000301	0.000326	CcSEcCtD
Paliperidone—Constipation—Prednisone—systemic scleroderma	0.000299	0.000323	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—systemic scleroderma	0.000294	0.000319	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000292	0.000316	CcSEcCtD
Paliperidone—Infection—Methotrexate—systemic scleroderma	0.00029	0.000314	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—systemic scleroderma	0.000288	0.000312	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000286	0.00031	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000286	0.000309	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000286	0.000309	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—systemic scleroderma	0.000284	0.000307	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—systemic scleroderma	0.000278	0.000301	CcSEcCtD
Paliperidone—Urticaria—Prednisone—systemic scleroderma	0.000278	0.0003	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—systemic scleroderma	0.000276	0.000299	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—systemic scleroderma	0.000276	0.000299	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—systemic scleroderma	0.000273	0.000295	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000266	0.000288	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—systemic scleroderma	0.000264	0.000286	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—systemic scleroderma	0.000262	0.000284	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—systemic scleroderma	0.00026	0.000282	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—systemic scleroderma	0.00026	0.000281	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—systemic scleroderma	0.000257	0.000279	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—systemic scleroderma	0.000257	0.000278	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—systemic scleroderma	0.000254	0.000275	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000252	0.000273	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—systemic scleroderma	0.000252	0.000272	CcSEcCtD
Paliperidone—Asthenia—Prednisone—systemic scleroderma	0.000251	0.000271	CcSEcCtD
Paliperidone—Pain—Methotrexate—systemic scleroderma	0.00025	0.00027	CcSEcCtD
Paliperidone—Pruritus—Prednisone—systemic scleroderma	0.000247	0.000268	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000241	0.00026	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—systemic scleroderma	0.000239	0.000259	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000239	0.000258	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—systemic scleroderma	0.000232	0.000251	CcSEcCtD
Paliperidone—Dizziness—Prednisone—systemic scleroderma	0.000231	0.00025	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—systemic scleroderma	0.000231	0.00025	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—systemic scleroderma	0.000231	0.00025	CcSEcCtD
Paliperidone—Vomiting—Prednisone—systemic scleroderma	0.000222	0.00024	CcSEcCtD
Paliperidone—Rash—Prednisone—systemic scleroderma	0.00022	0.000238	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—systemic scleroderma	0.00022	0.000238	CcSEcCtD
Paliperidone—Headache—Prednisone—systemic scleroderma	0.000219	0.000237	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000215	0.000233	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—systemic scleroderma	0.00021	0.000227	CcSEcCtD
Paliperidone—Nausea—Prednisone—systemic scleroderma	0.000208	0.000225	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—systemic scleroderma	0.000207	0.000224	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—systemic scleroderma	0.0002	0.000216	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—systemic scleroderma	0.000193	0.000209	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—systemic scleroderma	0.000186	0.000201	CcSEcCtD
Paliperidone—Rash—Methotrexate—systemic scleroderma	0.000184	0.000199	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—systemic scleroderma	0.000184	0.000199	CcSEcCtD
Paliperidone—Headache—Methotrexate—systemic scleroderma	0.000183	0.000198	CcSEcCtD
Paliperidone—Nausea—Methotrexate—systemic scleroderma	0.000173	0.000188	CcSEcCtD
